[{"Assets_0_Q2_USD":8735500.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-8898200.0,"NetIncomeLoss_1_Q2_USD":-5335900.0,"NetIncomeLoss_2_Q2_USD":-11545800.0,"StockholdersEquity_0_Q2_USD":-3630400.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]